Orthopaedic Surgery

Orthopaedic Surgery
Audio Summaries

The literature in orthopaedic surgery doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

14 active journals1,756 audio summaries

Recent summaries

The latest articles summarized from orthopaedic surgery journals.

Complications and Failures following Extensor Mechanism Reconstruction in Revision Total Knee Arthroplasty.

The Journal of arthroplasty|Nov 20, 2026

This study used a national claims database to compare complications and treatment failures (including fusion or amputation) in revision total knee arthroplasty with versus without extensor mechanism reconstruction (EMR), in both septic and aseptic cases. The authors asked whether adding EMR increases the risk of wound problems, reoperations, and ultimately arthrodesis or amputation. They found that EMR was linked to higher rates of wound dehiscence in both groups and, in aseptic revisions specifically, to greater odds of subsequent debridement, grafting, flap procedures, and amputation, suggesting the added soft-tissue burden drives amputation risk.

Stratified Diagnostic Thresholds by Infection Chronicity Resolve the Controversy in Unicompartmental Knee Arthroplasty Periprosthetic Joint Infection: A Prospective Study.

The Journal of arthroplasty|Nov 20, 2026

This prospective single-center study of 77 revision unicompartmental knee arthroplasty patients asked whether synovial fluid markers (white blood cell count, polymorphonuclear percentage, and neutrophil gelatinase-associated lipocalin, NGAL) should use different diagnostic cutoffs for acute versus chronic periprosthetic joint infection. ROC analysis showed that acute infection required higher cutoffs (SF-WBC >10,020/μL, PMN% >81%) than chronic infection (SF-WBC <2,770/μL, PMN% >62%), and synovial NGAL performed strongly in both groups. Because the study is small, exploratory, and lacks external validation, the authors conclude that these chronicity-specific thresholds need confirmation in larger multicenter cohorts before routine clinical use.

There is a Marked Temporal Variation in the Level of Serological Markers Used for Diagnosis of Periprosthetic Joint Infection.

The Journal of arthroplasty|Nov 20, 2026

This study examined whether ESR and CRP levels change over time enough in patients awaiting revision arthroplasty to alter periprosthetic joint infection (PJI) diagnoses. In a cohort of 218 patients with repeated pre-revision measurements, ESR rose about 5.9% per day when initially low, and CRP fell about 4.9% per day when initially high, with the greatest variability seen when initial ESR was low. The authors conclude that these temporal fluctuations can move results above or below MSIS diagnostic thresholds, potentially compromising the accuracy of serological testing for PJI.

Reliability of Ultrasound-Based Metrics for Patellofemoral Instability: A Systematic Review.

Journal of pediatric orthopedics|Nov 20, 2026

This systematic review asked whether ultrasound-based measurements of the patellofemoral joint are reliable and accurate enough to support a standardized imaging protocol for patellofemoral instability, as an alternative to MRI and CT. Across 33 studies (3,263 knees), trochlear morphology and patellar height measures showed good-to-excellent reliability, while cartilaginous sulcus angle and trochlear facet asymmetry were less reliable, and ultrasound detected soft-tissue and osteochondral injuries with about 90–100% accuracy. The authors conclude that ultrasound shows promise for a standardized patellofemoral protocol, but pediatric validation and standardized image acquisition are still needed before widespread clinical use.

Outcomes in Men versus Women After Primary Total Knee Arthroplasty: A Systematic Review.

The Journal of arthroplasty|Nov 19, 2026

This systematic review asked whether outcomes after primary total knee arthroplasty differ between men and women, synthesizing 24 studies covering about 2.6 million patients. The authors found that men generally reported slightly higher PROM scores, but these differences were usually below the minimal clinically important difference and often disappeared after adjusting for preoperative status, while men showed higher rates of infection, reoperation, and revision. They conclude that sex-based differences are small and may reflect worse preoperative health in women rather than an independent effect of sex, though the evidence is not entirely consistent.

Association Between Quantitatively Assessed Lateral Trochlear Osteophyte Severity and Three-Year Outcomes After Medial Unicompartmental Knee Arthroplasty.

The Journal of arthroplasty|Nov 19, 2026

This retrospective cohort study of 221 knees undergoing medial unicompartmental knee arthroplasty asked whether the severity of lateral trochlear osteophytes (LTO), quantified on Merchant-view radiographs using a novel joint space occupancy ratio (JSOR), affects patient-reported outcomes. At three years, patients with an LTO had slightly higher pain scores (VAS 2.0 vs 1.7) and lower Kujala scores (87.5 vs 89.2) than those without, with more severe osteophytes (JSOR ≥50%) associated with somewhat worse results. However, these differences fell below minimal clinically important difference thresholds, and over 95% of patients in all groups achieved meaningful improvement, so the authors suggest JSOR may aid counseling but should not guide decisions alone.

Intra-Articular Injection Into a Nonoperative Joint Within 90 Days Before Total Knee Arthroplasty is Associated With Increased Revision.

The Journal of arthroplasty|Nov 19, 2026

This retrospective cohort study of over 1 million patients undergoing primary total knee arthroplasty asked whether an intra-articular injection into a nonoperative joint within 90 days before surgery increases the risk of revision. Injection was associated with higher revision hazard at one year (HR 1.43) and six months (HR 1.52), but not at 90 days, and this association was driven mainly by periprosthetic joint infection. The authors suggest recent injection into a non-knee joint may matter for perioperative risk assessment, though the mechanism remains unclear.

Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology.

JAMA|Nov 19, 2026

This case series of 21 former American football players examined whether plasma endogenously cleaved microtubule-binding region tau (eMTBR-tau) could serve as an in vivo biomarker for chronic traumatic encephalopathy (CTE) tau tangle pathology, which currently can only be confirmed at autopsy. Plasma eMTBR-tau was significantly higher in CTE-positive donors than CTE-negative donors, and highest in high-stage CTE with comorbid Alzheimer disease neuropathologic change, with levels also correlating with neuropathologic tau burden. The authors conclude that plasma eMTBR-tau may be a feasible candidate biomarker for high-stage CTE, though larger validation studies are needed to establish diagnostic accuracy and specificity.

Assessing Multiple Treatment Regimens for Tuberculosis.

The New England journal of medicine|Nov 19, 2026

This phase 2 randomized trial (PARADIGM4TB) asked whether new four-drug regimens containing ganfeborole and/or BTZ-043 could shorten or improve tuberculosis treatment compared with the standard 24-week HRZE regimen, using early sputum culture clearance (log10 time-to-positivity slope) as the primary measure. Two regimens, ganfeborole-bedaquiline-pretomanid-moxifloxacin (BPMG) and BTZ-043-bedaquiline-delamanid-moxifloxacin (BDMT), showed a posterior probability of superiority over HRZE of 0.83 and 0.99, respectively, with acceptable safety profiles to advance to further evaluation. The results were used to select regimens for further study rather than to establish definitive efficacy.

Medical Imaging and Pediatric and Adolescent Brain Tumor Risk.

JAMA|Nov 19, 2026

This retrospective cohort study of about 3.7 million children in six US health systems and Ontario, Canada, asked whether cumulative brain radiation dose from medical imaging is associated with later brain or central nervous system tumors. The authors found a dose-related increase in risk, with hazard ratios rising from 1.12 for under 1 mGy to 3.85 for 150 mGy or more, and stronger associations for aggressive tumor types. They estimated roughly 1 excess brain tumor per 1,266 head CT examinations by age 21, supporting careful justification and dose minimization for pediatric imaging that uses ionizing radiation.

Start listening to orthopaedic surgery research

14-day free trial. Pick your journals and go.